The key reason for listing: a trip to Japan

Description of your first forum.
Post Reply
Mst.Rina1R
Posts: 47
Joined: Tue Jan 07, 2025 3:37 am

The key reason for listing: a trip to Japan

Post by Mst.Rina1R »

From providing food for employees and families to finally deciding to log into the capital market, Zhang Jiaming said that the decision was made only after the Lunar New Year this year.

In 2023, Dayan Biomedical tried to open up the Japanese market and established a Japanese subsidiary. It also talked with potential Japanese investors, even Japanese securities firms and listing authorities, and was persuaded to list in Japan. However, considering that it was not well-known in Japan, I decided to return to Taiwan to discuss with brokers. Finally, with the recognition of many securities firms and the encouragement of Lin Xiuming, chairman of the stock exchange, the listing was finalized in Taiwan.

The most important goal of listing is to obtain more resources from the capital market.

This is because Dayan Biomedical has two big goals in the future: one ghana telegram is to expand the Japanese and Australian markets; the other is to follow the factory-preserving model and is expected to build a broader territory for Dayan Biomedical through the merger and acquisition of foreign companies.

The reason why overseas markets choose Japan and Australia is because the two have completely different characteristics. "Japan is very medicinal, while Australia focuses on nature." Zhang Jiaming said that it is expected that Japan's Daiyan Biomedical will launch in the first half of next year. We will use local raw materials, manufacture locally, and sell to local Japanese residents. If the operation goes smoothly after the second quarter, we will increase investment in resources. "Another point is that digital marketing in Japan is relatively weak. Dayan Biomedical relies on marketing in Taiwan. Yes, we (Japan) would have had a little advantage in the past.”

In addition, Dayan Biomedical is also targeting Southeast Asia, making Japan's Dayan Biomedical an important node, which can avoid tariff issues, and because it originates from Japan, it can add more trust. If the Japanese and Australian markets stabilize, they will not rule out selling products back to Taiwan through cross-border e-commerce on the premise of complying with Taiwan's regulations.
Post Reply